Nifedipine and Embolic stroke - a phase IV clinical study of FDA data

Summary:

Embolic stroke is reported as a side effect among people who take Nifedipine (nifedipine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Xarelto, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Embolic stroke when taking Nifedipine. It is created by eHealthMe based on reports of 52,610 people who have side effects when taking Nifedipine from the FDA, and is updated regularly.

What is Nifedipine?

Nifedipine has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 53,459 Nifedipine users. Check the latest studies of Nifedipine.

What is Embolic stroke?

Embolic stroke (stroke due to obstruction due to an embolus) is found to be associated with 365 drugs and 543 conditions by eHealthMe. Check the latest studies of Embolic stroke.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

52,610 people reported to have side effects when taking Nifedipine.
Among them, 21 people (0.04%) have Embolic stroke.

Among these 21 people:

How long have people been on Nifedipine when they have Embolic stroke? *

What is the gender of people who have Embolic stroke when taking Nifedipine? *

female: 31.58 %
male: 68.42 %

What is the age of people who have Embolic stroke when taking Nifedipine? *

What are other drugs people take besides Nifedipine? *

What are other side effects people have besides Embolic stroke? *

Cerebral Infarction (less blood supply to brain resulting tissue damage): 6 people, 28.57%
Hemiplegia (paralysis of one side of the body): 4 people, 19.05%
Speech Impairment (Adult) (inability to speak (adult)): 4 people, 19.05%
Pain In Extremity: 3 people, 14.29%
Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 3 people, 14.29%
Escherichia Test Positive: 3 people, 14.29%
Carotid Arterial Embolus (obstruction in carotid artery): 3 people, 14.29%
C-Reactive Protein Increased: 3 people, 14.29%
Fever: 3 people, 14.29%
Atrial Thrombosis (blood clot that develops in an artery): 3 people, 14.29%

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 10 people, 47.62%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 14.29%
Intracardiac Thrombus (presence of a circumscribed mass with heart wall): 3 people, 14.29%
Atrial Thrombosis (blood clot that develops in an artery): 3 people, 14.29%
Haemorrhage (bleeding): 3 people, 14.29%
Cerebellar Haemorrhage (bleeding in cerebeller): 3 people, 14.29%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 1 person, 4.76%
Cardiac Failure Chronic: 1 person, 4.76%
Cerebral Artery Embolism (sudden blocking of an artery by a clot or foreign material): 1 person, 4.76%
Cerebral Infarction (less blood supply to brain resulting tissue damage): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Nifedipine and have Embolic stroke?

- Check whether Embolic stroke is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nifedipine:

Nifedipine (53,459 reports)

Embolic stroke treatments and more:

Embolic stroke (4,762 reports)

Browse all side effects of Nifedipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Embolic stroke:

Embolic stroke (365 drugs)

Browse all the conditions that are associated with Embolic stroke:

Embolic stroke (543 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nifedipine (the active ingredients of Nifedipine) and Nifedipine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.